Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis

@article{Abdellatif2018AssociationBE,
  title={Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis},
  author={Mohammed Abdellatif and Sherief Ghozy and Mohamed Gomaa Kamel and Sameh Samir Elawady and Mohamed Mohy Eldeen Ghorab and Andrew Wassef Attia and Truong Thi Huyen and Diep Trong Vien Duy and Kenji Hirayama and Nguyen Tien Huy},
  journal={European Journal of Pediatrics},
  year={2018},
  volume={178},
  pages={301-314}
}
Macrolides are bacteriostatic antibiotics with a broad spectrum of activity against Gram-positive bacteria. The aim of this study was to systematically review and meta-analyze the association between infantile hypertrophic pyloric stenosis (IHPS) and macrolides. Nine databases were searched systematically for studies with information on the association between macrolides and IHPS. We combined findings using random effects models. Our study revealed 18 articles investigating the association… 

Environmental exposure in the etiology of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis

TLDR
Lower maternal educational level, maternal smoking, and white ethnicity are associated with a significantly increased risk of infantile hypertrophic pyloric stenosis, while folic acid use seems non-significantly associated with IHPS risk.

The Dutch Incidence of Infantile Hypertrophic Pyloric Stenosis and the Influence of Seasons.

TLDR
The results showed no changing trend in incidence and no seasonal variation and the average IHPS incidence in the Netherlands was 1.28 per 1,000 LB.

Protocol: A systematic review and meta-analysis of the role of fetal and infantile environmental exposure in etiopathogenesis of infantile hypertrophic pyloric stenosis

TLDR
The effect of the effect of occupational and environmental factors and role of nitric oxide metabolism in the etiopathogenesis of infantile hypertrophic pyloric stenosis is clarified by systematically reviewing the literature.

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis

TLDR
Treatment with emricasan is more effective in improving liver function and apoptosis parameters compared to placebo, with a well-tolerated safety profile, however, due to the poor quality of the analyzed studies, the small number of trials and patients, and the short follow-up periods, more robust trials are still warranted.

Prenatal Exposure to Antibiotics and Development of Epilepsy in Children

TLDR
The findings indicated that pregnant women should receive the indicated antibiotic treatment with no fear of the development of epilepsy in their children, and the specificity analysis strongly suggested the possibility of confounding by indication.

The Safety and Effectiveness of Laparoscopic Pyloromyotomy Using 3-mm Electrocautery Hook versus Open Surgery for Treatment of Hypertrophic Pyloric Stenosis in Infants

TLDR
Open and laparoscopic pyloromyotomy are equally safe and effective in treatment of hypertrophic pyloric stenosis and Laparoscopic technique is associated with faster recovery, shorter duration of surgery and short duration of hospital stay.

Introduction of transumbilical surgical access in patients with hypertrophic pyloric stenosis at Karl Heusner Memorial Hospital

It is not really a congenital malformation but a genetically programmed condition that causes progressive hypertrophy of the pyloric muscular layer resulting in obstruction of the gastric outlet. As

Development of a Validated Stability Indicating Method for Quantification of Amoxicillin, Clarithromycin and Lansoprazole in Bulk and Pharmaceutical Dosage form by RP-HPLC

Objective: The main objective of the present work is to develop an efficient, unique, reliable Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method for the simultaneous

References

SHOWING 1-10 OF 54 REFERENCES

Post-natal erythromycin exposure and risk of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis

TLDR
This study demonstrates a significant association between post-natal erythromycin exposure and development of IHPS, which seems stronger when exposure occurs in the first 2 weeks of life.

No association between macrolide treatment in infancy and later pyloric stenosis in Sweden

TLDR
In a nationwide cohort of 582,494 children born between July 2005 and December 2010 in Sweden, the use of macrolides and the risk of IHPS was examined and data do not contradict the findings of Lund et al. and cannot rule out that early macrolide exposure contributes to IH PS.

Azithromycin in Early Infancy and Pyloric Stenosis

TLDR
Ingestion of oral azithromycin and erythromycin places young infants at increased risk of developing infantile hypertrophic pyloric stenosis, and this association is strongest if the exposure occurred in the first 2 weeks of life, but persists although to a lesser degree in children between 2 and 6 weeks of age.

Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis.

TLDR
This study confirms an association between systemic erythromycin in infants and subsequent IHPS, with the highest risk in the first 2 weeks of age, and a possible association with maternal macrolide therapy in late pregnancy requires further study.

Risk of Infantile Hypertrophic Pyloric Stenosis after Maternal Postnatal Use of Macrolides

TLDR
The use of macrolides during breast-feeding increases the risk of infantile hypertrophic pyloric stenosis, and after stratification for gender they were 10.3 [95% confidence interval 1.2–92.3] for girls and 2.0 (95% CI 0.5–8.4) for boys.

The safety of macrolides during lactation.

TLDR
Rates and types of minor adverse reactions in breastfed infants exposed to a macrolide or amoxicillin in breastmilk were comparable and Macrolide exposure during breastfeeding was not associated with pyloric stenosis, although larger prospective studies are required to confirm the observation.

Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis.

TLDR
The significant increase in pyloric stenosis in children with very early exposure to erythromycin is consistent with reports of other investigators and should be weighed carefully prior to initiating such therapy in young infants.

Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study

TLDR
Treatment of young infants with macrolide antibiotics was strongly associated with infantile hypertrophic pyloric stenosis (IHPS) and should therefore only be administered if potential treatment benefits outweigh the risk.

Balancing competing risks: perinatal exposure to macrolides increases the risk of infantile hypertrophic pyloric stenosis

TLDR
Commentary on the use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study finds it less clear whether maternal use in late pregnancy or while breastfeeding also poses a risk.
...